Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laquinimod in SLE Patients With Active Lupus Arthritis
NCT01085084Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Oct 2010
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of laquinimod in systemic lupus erythematosus (SLE), sponsored by Teva Pharmaceutical Industries Ltd.. Started Oct 2010; status: completed.
02
Drugs
laquinimod
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT01085084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01085084.